Roche Holding AG (RO) - Total Liabilities

Latest as of June 2026: CHF61.48 Billion CHF ≈ $77.73 Billion USD

Based on the latest financial reports, Roche Holding AG (RO) has total liabilities worth CHF61.48 Billion CHF (≈ $77.73 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Roche Holding AG long-term investment intensity to see how much of total assets are deployed in long-term investments.

Roche Holding AG - Total Liabilities Trend (1998–2025)

This chart illustrates how Roche Holding AG's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Roche Holding AG asset portfolio.

Roche Holding AG Competitors by Total Liabilities

The table below lists competitors of Roche Holding AG ranked by their total liabilities.

Company	Country	Total Liabilities
Astera Labs, Inc. NASDAQ:ALAB	USA	$205.80 Million
Teradyne Inc NASDAQ:TER	USA	$1.37 Billion
NATWEST GROUP SP.ADR/2 F:RYS	Germany	€705.97 Billion
Hyundai Motor Co. Ltd. KO:005380	Korea	₩259.10 Trillion
Hindustan Unilever Limited NSE:HINDUNILVR	India	Rs328.72 Billion
Swedbank AB (publ) ST:SWED-A	Sweden	Skr3.10 Trillion
Polski Koncern Naftowy ORLEN SA WAR:PKN	Poland	zł120.50 Billion
Becton Dickinson and Company NYSE:BDX	USA	$26.31 Billion

Liability Composition Analysis (1998–2025)

This chart breaks down Roche Holding AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Roche Holding AG net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.23	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.88	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.63	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Roche Holding AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Roche Holding AG (1998–2025)

The table below shows the annual total liabilities of Roche Holding AG from 1998 to 2025.

Year	Total Liabilities	Change
2025-12-31	CHF62.82 Billion ≈ $79.43 Billion	-4.29%
2024-12-31	CHF65.64 Billion ≈ $82.99 Billion	+14.75%
2023-12-31	CHF57.20 Billion ≈ $72.32 Billion	+1.90%
2022-12-31	CHF56.14 Billion ≈ $70.97 Billion	-12.25%
2021-12-31	CHF63.97 Billion ≈ $80.88 Billion	+37.97%
2020-12-31	CHF46.37 Billion ≈ $58.62 Billion	-1.82%
2019-12-31	CHF47.22 Billion ≈ $59.70 Billion	-1.93%
2018-12-31	CHF48.15 Billion ≈ $60.88 Billion	+1.01%
2017-12-31	CHF47.67 Billion ≈ $60.27 Billion	-5.45%
2016-12-31	CHF50.42 Billion ≈ $63.74 Billion	-3.90%
2015-12-31	CHF52.46 Billion ≈ $66.33 Billion	-2.81%
2014-12-31	CHF53.98 Billion ≈ $68.25 Billion	+31.90%
2013-12-31	CHF40.93 Billion ≈ $51.74 Billion	-14.87%
2012-12-31	CHF48.08 Billion ≈ $60.78 Billion	+2.09%
2011-12-31	CHF47.09 Billion ≈ $59.54 Billion	-4.59%
2010-12-31	CHF49.36 Billion ≈ $62.40 Billion	-24.24%
2009-12-31	CHF65.15 Billion ≈ $82.37 Billion	+192.59%
2008-12-31	CHF22.27 Billion ≈ $28.15 Billion	-10.49%
2007-12-31	CHF24.88 Billion ≈ $31.45 Billion	-9.87%
2006-12-31	CHF27.60 Billion ≈ $34.89 Billion	-0.08%
2005-12-31	CHF27.62 Billion ≈ $34.92 Billion	+11.46%
2004-12-31	CHF24.78 Billion ≈ $31.33 Billion	-18.27%
2003-12-31	CHF30.32 Billion ≈ $38.34 Billion	-20.67%
2002-12-31	CHF38.22 Billion ≈ $48.32 Billion	-7.72%
2001-12-31	CHF41.42 Billion ≈ $52.36 Billion	+10.45%
2000-12-31	CHF37.50 Billion ≈ $47.41 Billion	-7.25%
1999-12-31	CHF40.43 Billion ≈ $51.11 Billion	+22.28%
1998-12-31	CHF33.06 Billion ≈ $41.80 Billion	--

About Roche Holding AG

SW:RO Switzerland Drug Manufacturers - General

Market Cap

$49.72 Billion

CHF39.33 Billion CHF

Market Cap Rank

#552 Global

#9 in Switzerland

Share Price

CHF368.60

Change (1 day)

-0.32%

52-Week Range

CHF265.40 - CHF382.20

All Time High

CHF402.61